Wedmont Private Capital Grows Stock Holdings in Sotera Health (NASDAQ:SHC)

Wedmont Private Capital boosted its holdings in Sotera Health (NASDAQ:SHC) by 6.5% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 10,915 shares of the company’s stock after purchasing an additional 664 shares during the quarter. Wedmont Private Capital’s holdings in Sotera Health were worth $169,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. CWM LLC raised its position in shares of Sotera Health by 86.1% during the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after acquiring an additional 993 shares in the last quarter. GAMMA Investing LLC increased its stake in Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after purchasing an additional 1,660 shares during the last quarter. Point72 DIFC Ltd raised its holdings in Sotera Health by 556.6% during the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock worth $78,000 after purchasing an additional 5,544 shares in the last quarter. Acadian Asset Management LLC lifted its position in shares of Sotera Health by 728.0% during the 2nd quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock worth $111,000 after buying an additional 8,248 shares during the last quarter. Finally, Sandia Investment Management LP acquired a new position in shares of Sotera Health in the 1st quarter valued at $120,000. 91.03% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SHC has been the topic of several research analyst reports. Barclays lifted their price target on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research report on Tuesday, August 6th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $15.70.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the sale, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 55.12% of the company’s stock.

Sotera Health Stock Up 0.8 %

Shares of NASDAQ:SHC opened at $15.32 on Monday. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The company has a debt-to-equity ratio of 5.46, a current ratio of 2.93 and a quick ratio of 2.59. The stock has a market cap of $4.34 billion, a P/E ratio of 109.43 and a beta of 2.07. The firm has a fifty day moving average price of $15.68 and a 200 day moving average price of $13.16.

Sotera Health (NASDAQ:SHC) last announced its earnings results on Monday, August 5th. The company reported $0.19 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.04. The business had revenue of $277.00 million during the quarter, compared to the consensus estimate of $266.45 million. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. The business’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.19 earnings per share. Sell-side analysts predict that Sotera Health will post 0.64 EPS for the current year.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.